Serial Number
97898955
Owner
Hepalink USA Inc.Attorney
Gordon M. WrightFirst Use Date
Jan 1, 1976
Filing Date
Apr 20, 2023
SPL Trademark
Serial Number: 97898955 • Registration: 7355282
Trademark Classes
Owner Contact Info
2005 Cabot Boulevard West, Suite 200
Langhorne, PA 190471885
Entity Type: 03
Legal Representation
Trademark Details
Filing Date
April 20, 2023
Registration Date
April 9, 2024
First Use Anywhere
January 1, 1976
First Use in Commerce
January 1, 1976
Published for Opposition
January 23, 2024
Goods & Services
Manufacturing services for others in a cGMP ("Current Good Manufacturing Practice") compliant facility in the field of therapeutic compounds, namely, the extraction, isolation and purification of naturally derived and fermentation-derived therapeutic compounds
Pharmaceutical products and preparations containing active pharmaceutical ingredients, namely, pharmaceutical grade Heparin Sodium, pharmaceutical grade Pancreatin, and pharmaceutical grade Pancrealipase, for use in humans for the prevention and treatment of thrombotic events and to treat pancreatic insufficiency and related diseases; Pharmaceutical products and preparations, namely, anticoagulants; pharmaceutical products and preparations for the testing, sampling and identification of viruses, namely, medical diagnostic reagents and assays for testing of body fluids; Chemical preparations for sanitary use; Chemical preparations for treating mildew; Diagnostic preparations for medical purposes; Injectable pharmaceuticals for treatment of anaphylactic reactions; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations for skin care; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for treating thyroid conditions; Pharmaceutical preparations for wounds; Diagnostic preparations for use with medical devices; Pharmaceutical preparations for treating thrombotic events and pancreatic insufficiency for use with medical devices for drug delivery; Pharmaceutical preparations for ophthalmological use, namely, for treating eye diseases and disorders; none of the foregoing for use with animals
Pharmaceutical contract development in a cGMP ("Current Good Manufacturing Practice") compliant facility in the field of therapeutic compounds, namely, the extraction, isolation and purification of naturally derived and fermentation-derived therapeutic compounds